why choose us

Clinical Trials Search

Showing 3,080 of 131,434 result(s)
Nursing Students and Artificial Intelligence

Status: COMPLETED

Condition: Nursing Students

Interventions:

Date: 2024-09-30

Clinical Trial to Evaluate the PK Interactions of YHR2402 Monotherapy and YHR2402 and YHR2403 Co-Administration in Healthy Volunteers

Status: COMPLETED

Condition: Healthy Volunteers

Interventions: Test Drug: YHR2402

Date: 2024-09-30

The Effect of Mandala Art Therapy on Anxiety and Pain

Status: COMPLETED

Condition: Total Hip Replacement

Interventions: The Effect of Mandala Art Therapy on Anxiety and Pain in Patients

Date: 2024-09-30

The Effect of Methylprednisolone on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group

Status: COMPLETED

Condition: Sugammadex Reversal Time

Interventions: Patients will undergo standard noninvasive blood pressure monitoring, electrocardiogram, peripheral oxygen saturation (SpO2), and capnography.
Af

Date: 2024-09-30

Daridorexant to Prevent Delirium After Heart Surgery

Status: COMPLETED

Condition: POSTOPERATIVE DELIRIUM

Interventions: Administered consistent with labeling from the US Food and Drug Administration.

Date: 2024-09-30

The Impact of Chewing Food on Stroke Patients

Status: COMPLETED

Condition: Stroke

Interventions: Daily foods like candies and dumplings will be cut into small pieces.
Patients will chew them before each rehabilitation training and then spit t

Date: 2024-09-30

Hypertension as a Reason for Concellation of Elective Minor Abdominal Surgery

Status: COMPLETED

Condition: Hypertension Secondary

Interventions:

Date: 2024-09-30

Survey Stroke Units in Argentina

Status: COMPLETED

Condition: Surveys and Questionnaires

Interventions: no intervention

Date: 2024-09-30

Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study

Status: COMPLETED

Condition: Intermittent Fasting

Interventions: Ketone and blood glucose monitoring with Abbott Optium Neo up to 10 times per day to observe GKI dynamics for gamification of adherence.

Date: 2024-09-30

Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS Glargine (G), United States (US)-Lantus®, and European Union (EU)-Lantus®

Status: COMPLETED

Condition: Healthy Participants

Interventions: Single subcutaneous dose of 0.5 IU;kg administered over three periods

Date: 2024-09-30